Wells Fargo analyst Stephen Baxter upgraded Molina Healthcare to Equal Weight from Underweight with a price target of $420, up from $367. The firm says that while certain guidance assumptions leave it concerned on 2024, Molina should have “several shots on goal” in upcoming Medicaid requests for proposals and its recent track record has been very strong. Molina has several opportunities in large Medicaid proposals to enter new states or increase share in existing states, the analyst tells investors in a research note. Wells is “increasingly unwilling” to bet against the company in the upcoming cycle.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MOH:
- Molina Healthcare Inc’s New Economy & Political Environment Risk – A Cause for Worry?
- Molina Healthcare price target lowered to $357 from $375 at Deutsche Bank
- Molina Healthcare price target raised to $395 from $380 at UBS
- Molina Healthcare sees FY24 EPS above $23.50, consensus $23.57
- Molina Healthcare reports FY23 MCR 88.1%
